Kinetics of the levels of pro- and anti-inflammatory cytokines and vascular endothelial growth factor in serum and pleural fluid after major lung resection for lung cancer

Yonago Acta Medica

Volumn 45, Issue 2, 2002, Pages 49-57

  Taniguchi, Yuji ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cytokine; Cytokine production per hour (hourly production of cytokine); Lung cancer; Vascular endothelial growth factor; Wound healing

Indexed keywords

EID: 52549128319     PISSN: 05135710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Adzick NS. Wound healing: biologic and clinical features. In: Sabiston DC Jr, ed. Textbook of surgery: the biological basis of modern surgical practice. 15th ed. Philadelphia: WB Saunders Co.; 1997. p. 207-220.
2. Arenberg DA, Kunkel SL, Polverini PJ, Glass M, Burdick MD, Stricter RM. Inhibition of interleukin-8 reduces tumorigenesis of human non-small cell lung cancer in SCID mice. J Clin Invest 1996;97:2792-2802.
3. Asadullah K, Woiciechowsky C, Döcke WD, Liebenthal C, Wauer H, Kox W, et al. Immuno-depression following neurosurgical procedures. Crit Care Med 1995;23:1976-1983.
4. 121. Cancer Res 1995;55:5296-5301.
5. Atwell DM, Griehnik KP, Newman MF, Reves JG, McBride WT, Balance of proinflammatory and antiinflammatory cytokines at thoracic cancer operation. Ann Thorac Surg 1998;66:1145-1150.
6. Baggiolini M, Walz A, Kunkel S. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-1049.
7. Bicknell R, Harris AL. Novel growth regulatory factors and tumour angiogenesis. Eur J Cancer 1991;27:781-785.
8. Fine NA, Mustoe TA. Wound healing. In: Greenfield LJ. ed. Surgery: scientific principles and practice. 2nd ed. Philadelphia: Lippincott-Raven; 1997. p. 67-83.
9. Folkman J, Watson K, Ingber D, Hanahan D. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989;339:58-61.
10. Fontanini G, Vignati S, Boldrini L, Chiné S, Silvestri V, Lucchi M, et al. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 1997;3:861-865.
11. Gabrilovich DI, Chen HL, Girgis KR, Cunningham HT, Meny GM, Nadaf S, et al. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nature Med 1996;2:1096-1103.
12. Grad S, Ertel W, Keel M, Manger M, Vonderschmitt DJ, Maly FE. Strongly enhanced serum levels of vascular endothelial growth factor (VEGF) after polytrauma and burn. Clin Chem Lab Med 1998;36:379-383.
13. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364.
14. Hangai N. Change of tissue oxygen tension and blood flow of the trachea after tracheoplasty. Kikanshigaku 1996;18:646-653 (in Japanese with English abstract).
15. Hattori T, Hamai Y, Takiyama W, Hirai T, Ikeda T. Enhancing effect of thoracotomy on tumor growth in rats with special reference to the duration and timing of the operation. Gann (Jpn J Cancer Res) 1980;71:280-284.
16. Hirai T, Yoshimoto A, Iwata T, Yamashita Y, Kuwahara M, Toge T. Enhancing effect of thoraco-laparotomy on liver metastasis and the role played by active oxygens in its mechanism. Surg Today (Jpn J Surg) 1997;27:1040-1045.
17. Imoto H, Osaki T, Taga S, Ohgami A, Ichiyoshi Y, Yasumoto K. Vascular endothelial growth factor expression in non-small-cell lung cancer: prognostic significance in squamous cell carcinoma. J Thorac Cardiovasc Surg 1998;115:1007-1014.
18. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma: association with angiogenesis and tumor progression. Cancer 1997;79:206-213.
19. Ishimura K, Tsubouchi T, Okano K, Maeba T, Maeta H. Wound healing of intestinal anastomosis after digestive surgery under septic conditions: participation of local interleukin-6 expression. World J Surg 1998;22:1069-1076.
20. Kawahito K, Kawakami M, Fujiwara T, Adachi H, Ino T. Interleukin-8 and monocyte chemotactic activating factor responses to cardiopulmonary bypass. J Thorac Cardiovasc Surg 1995;110:99-102.
21. Kawamura T, Inada K, Akasaka N, Wakusawa R. Ulinastatin reduces elevation of cytokines and soluble adhesion molecules during cardiac surgery. Can J Anaesth 1996;43:456-460.
22. Keane MP, Arenberg DA, Lynch JP III, Whyte RI, Iannettoni MD, Burdick MD, et al. The CXC chemokines, IL-8 and IP-10, regulate angiogenic activity in idiopathic pulmonary fibrosis. J Immunol 1997;159:1437-1443.
23. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992;258:1798-1801.
24. Krohn CD, Reikerås O, Mollnes TE, Aasen AO. Complement activation and release of interleukin-6 and tumour necrosis factor-α in drained and systemic blood after major orthopaedic surgery. Eur J Surg 1998;164:103-108.
25. Liebold A, Keyl C, Birnbaum DE. The heart products but the lungs consume proinflammatory cytokines following cardiopulimonary bypass. Eur J Cardiothorac Surg 1999;15:340-345.
26. Matsuguchi T, Okamura S, Kawasaki C, Shimoda K, Omori F, Hayashi S, et al. Constitutive production of granulocyte colony-stimulating factor and interleukin-6 by a human lung cancer cell line, KNSY: gene amplification and increased mRNA stability. Eur J Haematol 1991;47:128-133.
27. Nissen NN, Polverini PJ, Koch AE, Volin MV, Gamelli RL, DiPietro LA. Vascular endothelial growth factor mediates angoigenic activity during the proliferative phase of wound healing. Am J Pathol 1998;152:1445-1452.
28. Risau W. Mechanisms of angiogenesis. Nature 1997;386:671-674.
29. Rowe DH, Huang J, Kayton ML, Thompson R, Troxel A, OToole KM, et al. Anti-VEGF antibody suppresses primary tumor growth and metastasis in an experimental model of Wilms' tumor. J Pediatr Surg 2000;35:30-33.
30. Sakamoto K, Arakawa H, Mita S, Ishiko T, Ikei S, Egami H, et al. Elevation of circulating interleukin 6 after surgery: factors influencing the serum level. Cytokine 1994;6:181-186.
31. Sato Y, Oshima T, Kondo Y. Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 1999;265:194-199.
32. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
33. Steinberg JB, Kapelanski DP, Olson JD, Weiler JM. Cytokine and complement levels in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1993;106:1008-1016.
34. Steinbrech DS, Mehrara BJ, Chau D, Rowe NM, Chin G, Lee T, et al. Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 1999;42:514-520.
35. Teoh KHT, Bradley CA, Gauldie J, Burrows H. Steroid inhibition of cytokine-mediated vasodilation after warm heart surgery. Circulation 1995;92:347-353.
36. Waller DA, Keavey P, Woodfine L, Dark JH. Pulmonary endothelial permeability changes after major lung resection. Ann Thorac Surg 1996;61:1435-1440.
37. Warren RS, Yuan H, Matli MR, Gillett NA, Ferrara N. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995;95:1789-1797.
38. Weissflog D, Kroegel C, Luttmann W, Grahmann PR, Hasse J. Leukocyte infiltration and secretion of cytokines in pleural drainage fluid after thoracic surgery. Chest 1999;115:1604-1610.
39. Yamamoto Y, Toi M, Kondo S, Matsumoto T, Suzuki H, Kitamura M, et al. Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients. Clin Cancer Res 1996;2:821-826. Corresponding author: Dr. Yuji Taniguchi